Ophthalmology Doctors in Fort Worth, TX Accepting Medicare

44 Ophthalmology doctors found. Showing 41 - 44

Aziz Samir Abdul-rahim, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1201 Summit Ave, Fort Worth, TX 76102 Phone: 817-332-2020    Fax: 817-332-4797

Brian Edward Flowers, M.D. Ophthalmology - Glaucoma Specialist Medicare: Accepting Medicare Assignments Practice Location: 1201 Summit Ave, Fort Worth, TX 76102 Phone: 817-332-2020    Fax: 817-332-4797

Brian Adam Hajovsky, M.D. Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 1201 Summit Ave, Fort Worth, TX 76102 Phone: 817-332-2020    Fax: 817-332-4797

Phillip Howard Skinner, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1350 S Main St, #1100, Fort Worth, TX 76104 Phone: 817-332-4363    Fax: 817-332-5100

News Archive

A new study links 45,000 deaths a year to lack of insurance

Researchers find that 45,000 deaths a year can be linked to the lack of health insurance. But, some question the study's merits. CBS News reports that the study was conducted by a team "that tracked more than 9,000 people for up to 13 years, comparing the health of those with insurance to those without. After factoring in education and income, smoking, drinking and obesity, researchers found that the uninsured had about a 40 percent higher risk of death, linking 45,000 American deaths a year to lack of insurance. In 1993 it was 25 percent" (Axelrod, 9/17).

How the influenza virus takes control of a city, and implications for SARS-CoV-2

SARS-CoV-2 has spread around the world, passed across the borders of nations by travelers and cargo.

ASGE honors 27 endoscopy units with 'Certificate of Recognition'

The American Society for Gastrointestinal Endoscopy (ASGE) has recognized 27 endoscopy units as part of its program specifically dedicated to promoting quality in endoscopy, in all settings where it is practiced in the United States.

FDA announces required class-wide safety labeling changes for IR opioid pain medications

In a continuing effort to educate prescribers and patients about the potential risks related to opioid use, the U.S. Food and Drug Administration today announced required class-wide safety labeling changes for immediate-release (IR) opioid pain medications. Among the changes, the FDA is requiring a new boxed warning about the serious risks of misuse, abuse, addiction, overdose and death.

VolitionRx's NuQ blood-based diagnostic platform demonstrates promising results in clinical study

VolitionRx Limited, a life sciences company focused on developing diagnostic tests for cancer and other conditions, today announced that it has completed a blinded clinical study demonstrating that its NuQ® blood-based diagnostic platform is able to accurately detect 84% of early, surgically-treatable pancreatic cancers at high 92% specificity.

Read more Medical News

› Verified 9 days ago

• 1
• 2
• 3(current)